Health
Medicine to prevent patients from developing COVID-19 tested in UK – TASS
Scientists hope that people wouls be protected from COVID-19 for a period of between six months and one year
LONDON, December 26. /TASS/. A medicine that can potentially prevent people exposed to novel coronavirus from developing COVID-19 is now being tested in the United Kingdom, the Guardian reported on its website Friday.
The medicine, based on monoclonal antibodies created in a laboratory, was developed by UK-Swedish pharmaceutical company AstraZeneca and the University College London Hospitals.
“If we can prove that this treatment works and prevent people who are exposed to the virus going on to develop…
-
Noosa News20 hours agoBrisbane’s original 1979 electric trains take one last journey
-
Noosa News12 hours agoRainbow Beach surfer’s untold 7/7 story
-
General19 hours agoParis opens River Seine for public swimming for first time since 1923
-
Noosa News10 hours agoInfluenza cases nearly 20 per cent higher than 2024 as Queensland faces one of its worst flu seasons in years